Prot #CYP‐GVHD‐P2‐01: A Multicenter, Randomized, Double‐blind, Placebo‐Controlled Phase II Study to Investigate the Efficacy and Safety of CYP‐001 in Combination with Corticosteroids vs Corticosteroids Alone for the Treatment of High‐Risk Acute Graft Ve

Project: Research project

Project Details

Effective start/end date11/2/2311/2/26


  • Novella Clinical, LLC (Prot #CYP-GVHD-P2-01 // Prot #CYP-GVHD-P2-01)
  • Cynata Therapeutics Limited (Prot #CYP-GVHD-P2-01 // Prot #CYP-GVHD-P2-01)